Skip to main content

Patch Testing to Diphenylguanidine by the North American Contact Dermatitis Group (2013-2016).

Publication ,  Journal Article
Warshaw, EM; Gupta, R; Dekoven, JG; Fowler, JF; Silverberg, JI; Atwater, AR; Taylor, JS; Reeder, MJ; Maibach, HI; Sasseville, D; Belsito, DV ...
Published in: Dermatitis
2020

BACKGROUND/OBJECTIVES: Carba mix (CM, 3% petrolatum) contains 1,3-diphenylguanidine (DPG, 1%), zinc diethyldithiocarbamate (1%), and zinc dibutyldithiocarbamate (1%). Because DPG is a component of CM, DPG is often not tested separately. The purpose of this study was to determine the frequency of concomitant reactions to CM and DPG. METHODS: A retrospective analysis of the 2013-2016 North American Contact Dermatitis Group data was conducted. The study group consisted of patients with final interpretation of "allergic" to either DPG or CM. Reactions coded as irritant or doubtful/macular erythema (+/- and not interpreted as allergic) were excluded. RESULTS: A total of 10,457 patients were patch tested to both CM and DPG, and 610 (5.8%) had allergic reactions to either CM or DPG (CM only [n = 292, 47.9%], DPG only [n = 190, 31.1%], both [n = 128, 21.0%]). A total of 39.4% of CM-allergic patients reacted to DPG, and 59.7% of DPG-allergic patients reacted to CM. Analyses found that 25% (++/+++ subgroup) to 40% (all patients) of allergic reactions to DPG would have been missed by testing to CM alone. More than 70% of reactions to CM and DPG were +/- or +. CONCLUSIONS: Patch testing to CM will miss 25% to 40% of positive reactions to DPG. Both CM and DPG have a high frequency of +/- and + reactions.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Dermatitis

DOI

EISSN

2162-5220

Publication Date

2020

Volume

31

Issue

6

Start / End Page

350 / 358

Location

United States

Related Subject Headings

  • Patch Tests
  • Male
  • Humans
  • Guanidines
  • Female
  • Ditiocarb
  • Dermatology & Venereal Diseases
  • Dermatitis, Allergic Contact
  • Adult
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Warshaw, E. M., Gupta, R., Dekoven, J. G., Fowler, J. F., Silverberg, J. I., Atwater, A. R., … Zirwas, M. J. (2020). Patch Testing to Diphenylguanidine by the North American Contact Dermatitis Group (2013-2016). Dermatitis, 31(6), 350–358. https://doi.org/10.1097/DER.0000000000000629
Warshaw, Erin M., Rachit Gupta, Joel G. Dekoven, Joseph F. Fowler, Jonathan I. Silverberg, Amber R. Atwater, James S. Taylor, et al. “Patch Testing to Diphenylguanidine by the North American Contact Dermatitis Group (2013-2016).Dermatitis 31, no. 6 (2020): 350–58. https://doi.org/10.1097/DER.0000000000000629.
Warshaw EM, Gupta R, Dekoven JG, Fowler JF, Silverberg JI, Atwater AR, et al. Patch Testing to Diphenylguanidine by the North American Contact Dermatitis Group (2013-2016). Dermatitis. 2020;31(6):350–8.
Warshaw, Erin M., et al. “Patch Testing to Diphenylguanidine by the North American Contact Dermatitis Group (2013-2016).Dermatitis, vol. 31, no. 6, 2020, pp. 350–58. Pubmed, doi:10.1097/DER.0000000000000629.
Warshaw EM, Gupta R, Dekoven JG, Fowler JF, Silverberg JI, Atwater AR, Taylor JS, Reeder MJ, Maibach HI, Sasseville D, Belsito DV, DeLeo VA, Pratt MD, Marks JG, Zug KA, Zirwas MJ. Patch Testing to Diphenylguanidine by the North American Contact Dermatitis Group (2013-2016). Dermatitis. 2020;31(6):350–358.

Published In

Dermatitis

DOI

EISSN

2162-5220

Publication Date

2020

Volume

31

Issue

6

Start / End Page

350 / 358

Location

United States

Related Subject Headings

  • Patch Tests
  • Male
  • Humans
  • Guanidines
  • Female
  • Ditiocarb
  • Dermatology & Venereal Diseases
  • Dermatitis, Allergic Contact
  • Adult
  • 3204 Immunology